News for BioCryst Pharmaceuticals, Inc. - Google Finance

BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q1 Loss of 9c/Share

Tue, 07 May 2013 10:12:13 GMT

BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q1 Loss of 9c/Share
StreetInsider.com (subscription) - May 7, 2013

At the meeting, the FDA confirmed that BioCryst's proposed peramivir New Drug Application (NDA) content supports a reviewable NDA submission for the indication of acute uncomplicated influenza.

BioCryst Pharmaceuticals (BCRX) Releases Quarterly Earnings, Beats ... - Zolmax
Biocryst reports financial results for first quarter 2013 - News-Medical.net

BIOCRYST PHARMACEUTICALS, INC. : Commentary & Reports For: (NASDAQ ...

Wed, 24 Apr 2013 17:45:52 GMT

BIOCRYST PHARMACEUTICALS, INC. : Commentary & Reports For: (NASDAQ ...
4-traders (press release) - Apr 24, 2013

New York (April 24th, 2013) - BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) traded in the range of $1.75 and $1.97 during its latest trading session.

Stocks to Eyes On: Lumber Liquidators Holdings Inc. (NYSE:LL), BioCryst ...

Wed, 24 Apr 2013 18:46:48 GMT

Stocks to Eyes On: Lumber Liquidators Holdings Inc. (NYSE:LL), BioCryst ...
SBWire (press release) - Apr 24, 2013

Subsequently the company now anticipates full-year 2013 sales in the range of $913 million to $942 million up by $28 million and $22 million, earnings per diluted share in the range of $2.10 to $2.35, based on a diluted share count of approximately 28 ...

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) up by 11.67%, Cytokinetics Inc ... - NIS
Micro Cap Stocks of Biotech - BioCryst Pharmaceuticals, Inc., Cytokinetics ... - Techsonian (press release)

News Recap: Westinghouse Solar Inc, Tranzyme Inc, BioCryst Pharmaceuticals ...

Fri, 26 Apr 2013 12:58:15 GMT

News Recap: Westinghouse Solar Inc, Tranzyme Inc, BioCryst Pharmaceuticals ...
SBWire (press release) - Apr 26, 2013

Westinghouse Solar Inc. (PINK:WEST) decreased 8.27% and closed at $0.0377on a traded volume of 1.59 million shares.Westinghouse Solar, Inc. has negotiated a sub-license for use of the Westinghouse Solar brand and technologies in Australia.

Top Biotech Losers Athersys, Questcor Pharmaceuticals, Vivus Inc, (NASDAQ ...

Thu, 16 May 2013 10:43:45 GMT

Top Biotech Losers Athersys, Questcor Pharmaceuticals, Vivus Inc, (NASDAQ ...
Crazy Joys - May 16, 2013

Stocks of the Day Athersys, Inc (NASDAQ:ATHX) recently posted lower than expected quarterly results. Company posted first quarter 2013 adjusted net loss of 13 cents a share more than analysts' estimate of a loss of 10 cents.

Stock Losers: Raymond James Financial, Valassis Communications, Domtar ...

Fri, 26 Apr 2013 12:52:51 GMT

Stock Losers: Raymond James Financial, Valassis Communications, Domtar ...
SBWire (press release) - Apr 26, 2013

BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) increased 11.67% and closed at $2.01 on a traded volume XenoPort, Inc. (NASDAQ:XNPT)went down 7.85% and closed at $6.57 on a traded volume of 1.15 million shares.

AP Pharma, Inc. (OTC:APPA) up by 4.41%, BioCryst Pharmaceuticals Inc ...

Thu, 25 Apr 2013 17:02:42 GMT

AP Pharma, Inc. (OTC:APPA) up by 4.41%, BioCryst Pharmaceuticals Inc ...
NIS - Apr 25, 2013

New York, NY - (NISMAGAZINE) - 04/25/2013- A.P. Pharma, Inc. (OTC:APPA) moved 4.41% lower, at $0.325, was amongst the day losers, after opening at $0.34.

Savient Pharmaceuticals, Inc. (SVNT): Are Hedge Funds Right About This Stock?

Fri, 03 May 2013 11:33:37 GMT

Savient Pharmaceuticals, Inc. (SVNT): Are Hedge Funds Right About This Stock?
Insider Monkey (blog) - May 3, 2013

Is Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) ready to raly soon? Prominent investors are taking a bearish view. The number of bullish hedge fund bets retreated by 1 in recent months.

Micro Cap Investors Alert: Vocus, Inc. (NASDAQ:VOCS) and BioCryst ...

Thu, 25 Apr 2013 13:42:56 GMT

Micro Cap Investors Alert: Vocus, Inc. (NASDAQ:VOCS) and BioCryst ...
Techsonian (press release) - Apr 25, 2013

NEW YORK, April 25, 2013 - (Techsonain) - Vocus, Inc. (NASDAQ:VOCS), a top marketing cloud provider, declared on Wednesday, financial earnings for the first quarter concluded on March 31, 2013.

Semi-Annual Changes to the NASDAQ Biotechnology Index

Mon, 13 May 2013 12:09:12 GMT

Semi-Annual Changes to the NASDAQ Biotechnology Index
Wall Street Journal (press release) - May 13, 2013

Affymax, Inc. (Nasdaq:AFFY); BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX); Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT); and Savient Pharmaceuticals Inc. (Nasdaq:SVNT).